News
05-30-2022, 10:26 AM
Researchers at The University of Texas MD Anderson Cancer Center have developed an ultrasound-guided cancer immunotherapy platform that generates systemic antitumor immunity and improves the therapeutic efficacy of immune checkpoint blockade.
More... (https://www.news-medical.net/news/20220530/First-of-its-kind-platform-generates-antitumor-immunity-and-improves-responses-to-checkpoint-inhibitors.aspx)
More... (https://www.news-medical.net/news/20220530/First-of-its-kind-platform-generates-antitumor-immunity-and-improves-responses-to-checkpoint-inhibitors.aspx)